These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 16649835)

  • 1. Outcomes of late-life anxiety disorders during 32 weeks of citalopram treatment.
    Blank S; Lenze EJ; Mulsant BH; Dew MA; Karp JF; Shear MK; Houck PR; Miller MD; Pollock BG; Tracey B; Reynolds CF
    J Clin Psychiatry; 2006 Mar; 67(3):468-72. PubMed ID: 16649835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and tolerability of citalopram in the treatment of late-life anxiety disorders: results from an 8-week randomized, placebo-controlled trial.
    Lenze EJ; Mulsant BH; Shear MK; Dew MA; Miller MD; Pollock BG; Houck P; Tracey B; Reynolds CF
    Am J Psychiatry; 2005 Jan; 162(1):146-50. PubMed ID: 15625213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What is the threshold for symptomatic response and remission for major depressive disorder, panic disorder, social anxiety disorder, and generalized anxiety disorder?
    Bandelow B; Baldwin DS; Dolberg OT; Andersen HF; Stein DJ
    J Clin Psychiatry; 2006 Sep; 67(9):1428-34. PubMed ID: 17017830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and efficacy of escitalopram in the long-term treatment of generalized anxiety disorder.
    Davidson JR; Bose A; Wang Q
    J Clin Psychiatry; 2005 Nov; 66(11):1441-6. PubMed ID: 16420082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of subsyndromal depressive symptoms in middle-aged and older adults with schizophrenia: effect on functioning.
    Kasckow J; Lanouette N; Patterson T; Fellows I; Golshan S; Solorzano E; Zisook S
    Int J Geriatr Psychiatry; 2010 Feb; 25(2):183-90. PubMed ID: 19711335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Escitalopram treatment of pathological gambling with co-occurring anxiety: an open-label pilot study with double-blind discontinuation.
    Grant JE; Potenza MN
    Int Clin Psychopharmacol; 2006 Jul; 21(4):203-9. PubMed ID: 16687991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Escitalopram for comorbid depression and anxiety in elderly patients: A 12-week, open-label, flexible-dose, pilot trial.
    Mohamed S; Osatuke K; Aslam M; Kasckow J
    Am J Geriatr Pharmacother; 2006 Sep; 4(3):201-9. PubMed ID: 17062320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Efficacy and tolerability of escitalopram in anxiety disorders: a review].
    Pelissolo A
    Encephale; 2008 Sep; 34(4):400-8. PubMed ID: 18922243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Escitalopram in the treatment of panic disorder: a randomized, double-blind, placebo-controlled trial.
    Stahl SM; Gergel I; Li D
    J Clin Psychiatry; 2003 Nov; 64(11):1322-7. PubMed ID: 14658946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Venlafaxine extended release in the short-term treatment of depressed and anxious primary care patients with multisomatoform disorder.
    Kroenke K; Messina N; Benattia I; Graepel J; Musgnung J
    J Clin Psychiatry; 2006 Jan; 67(1):72-80. PubMed ID: 16426091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paroxetine in the treatment of generalized anxiety disorder: results of a placebo-controlled, flexible-dosage trial.
    Pollack MH; Zaninelli R; Goddard A; McCafferty JP; Bellew KM; Burnham DB; Iyengar MK
    J Clin Psychiatry; 2001 May; 62(5):350-7. PubMed ID: 11411817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjunctive therapy with pregabalin in generalized anxiety disorder patients with partial response to SSRI or SNRI treatment.
    Rickels K; Shiovitz TM; Ramey TS; Weaver JJ; Knapp LE; Miceli JJ
    Int Clin Psychopharmacol; 2012 May; 27(3):142-50. PubMed ID: 22302014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality of life outcomes in patients with obsessive-compulsive disorder: relationship to treatment response and symptom relapse.
    Hollander E; Stein DJ; Fineberg NA; Marteau F; Legault M
    J Clin Psychiatry; 2010 Jun; 71(6):784-92. PubMed ID: 20492845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Escitalopram : a review of its use in the management of major depressive and anxiety disorders.
    Waugh J; Goa KL
    CNS Drugs; 2003; 17(5):343-62. PubMed ID: 12665392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eszopiclone coadministered with escitalopram in patients with insomnia and comorbid generalized anxiety disorder.
    Pollack M; Kinrys G; Krystal A; McCall WV; Roth T; Schaefer K; Rubens R; Roach J; Huang H; Krishnan R
    Arch Gen Psychiatry; 2008 May; 65(5):551-62. PubMed ID: 18458207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and tolerability of mirtazapine versus citalopram: a double-blind, randomized study in patients with major depressive disorder. Nordic Antidepressant Study Group.
    Leinonen E; Skarstein J; Behnke K; Agren H; Helsdingen JT
    Int Clin Psychopharmacol; 1999 Nov; 14(6):329-37. PubMed ID: 10565799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Escitalopram for older adults with generalized anxiety disorder: a randomized controlled trial.
    Lenze EJ; Rollman BL; Shear MK; Dew MA; Pollock BG; Ciliberti C; Costantino M; Snyder S; Shi P; Spitznagel E; Andreescu C; Butters MA; Reynolds CF
    JAMA; 2009 Jan; 301(3):295-303. PubMed ID: 19155456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Venlafaxine extended release versus citalopram in patients with depression unresponsive to a selective serotonin reuptake inhibitor.
    Lenox-Smith AJ; Jiang Q
    Int Clin Psychopharmacol; 2008 May; 23(3):113-9. PubMed ID: 18408525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An open, non-randomised comparison of escitalopram and duloxetine for the treatment of subjects with Generalized Anxiety Disorder.
    Pierò A; Locati E
    Hum Psychopharmacol; 2011 Jan; 26(1):63-71. PubMed ID: 21305612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fixed-dose trial of the single isomer SSRI escitalopram in depressed outpatients.
    Burke WJ; Gergel I; Bose A
    J Clin Psychiatry; 2002 Apr; 63(4):331-6. PubMed ID: 12000207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.